NCT04723732View on ClinicalTrials.gov

Antiplaque, Antigingivitis and Anti-inflammatory Effects of Myrrh Mouthwash

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

August 15, 2018

Study Completion Date

December 15, 2018

Conditions
GingivitisDental Plaque
Interventions
DRUG

Myrrh mouthwash

1% mouthwash solution of commiphora myrrha, made from Commiphora Myrrha resin extract.

DRUG

Chlorhexidine mouthwash

0.2% mouthwash solution of chlorhexidine gluconate.

DRUG

Normal saline

0.9% solution of sodium chloride, containing 9 g/L Sodium Chloride (154 mEq/L sodium and 154 mEq/L chloride)

Trial Locations (1)

21589

King Abdul Aziz University, Jeddah

All Listed Sponsors
lead

King Abdulaziz University

OTHER

NCT04723732 - Antiplaque, Antigingivitis and Anti-inflammatory Effects of Myrrh Mouthwash | Biotech Hunter | Biotech Hunter